Covid vaccine: India's Corbevax gets Emergency Use Listing by WHO
Covid vaccine: Corbevax, India's COVID-19 vaccine, has been given an Emergency Use Listing by the World Health Organisation.
Corbevax is a protein subunit platform manufactured by the Indian pharmaceutical company Biological E Limited.
Mahima Datla, Managing Director of Biological E Ltd, stated, “We are pleased with the WHO Emergency Use Listing (EUL) because it would help us use the platform to continue developing COVID-19 vaccines as and when it starts impacting public health. We are confident that this endorsement from WHO will bolster our global fight against COVID-19.''
Punjab CM Mann, DGP Gaurav Yadav receive 'death threat' from SFJ chief Pannun
Supreme Court temporarily halts Shahi Idgah survey in Mathura
The Drugs Controller General of India (DCGI) had already approved Corbevax for restricted use in emergencies among adults, adolescents and young children in a sequential manner from December 2021 to April 2022.
It was also approved for use as India's first heterologous COVID-19 booster shot for adults aged 18 and above, in June 2022.
Pran Pratishta Ceremony: Check out schedule and key details
Ram Mandir event: Temple trust shares details of Pran Pratishtha ceremony
-
